Role of selenium in HIV infection

Nutrition Reviews

Volumn 68, Issue 11, 2010, Pages 671-681

  Stone, Cosby A ^a   Kawai, Kosuke ^b   Kupka, Roland ^b,c   Fawzi, Wafaie W ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Regional Office for West and Central Africa   (Senegal)

Author keywords

Dietary supplements; HIV; Micronutrients; Selenium; Trace minerals

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO; RNA; SELENIUM; SELENOMETHIONINE; SELENOPROTEIN; SODIUM SELENITE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIOXIDANT ACTIVITY; ARTICLE; CELLULAR IMMUNITY; CLINICAL TRIAL; COMORBIDITY; CROSS-SECTIONAL STUDY; DEVELOPED COUNTRY; DIARRHEA; DIET SUPPLEMENTATION; DISEASE COURSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; IMMUNOMODULATION; MORTALITY; NONHUMAN; OPPORTUNISTIC INFECTION; PUBLIC HEALTH PROBLEM; SELENIUM DEFICIENCY; UPREGULATION; VIRUS GENOME; VIRUS INHIBITION; VIRUS REPLICATION; ZINC DEFICIENCY;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; HIV INFECTIONS; HUMANS; SELENIUM; SELENOPROTEINS; TRACE ELEMENTS;

EID: 77958598935     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2010.00337.x     Document Type: Article

References (74)

1. UNAIDS. Report on the global AIDS epidemic. Geneva: UNAIDS; 2008.
2. Fawzi WW, Msamanga GI, Spiegelman D, et al. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med. 2004;351:23-32.
3. Sappey C, Legrand-Poels S, Best-Belpomme M, Favier A, Rentier B, Piette J. Stimulation of glutathione peroxidase activity decreases HIV type 1 activation after oxidative stress. AIDS Res Hum Retroviruses. 1994;10:1451-1461.
4. Diamond AM, Hu JY, Mansur DB. Glutathione peroxidase and viral replication: Implications for viral evolution and chemoprevention. Biofactors. 2001;14:205-210.
5. Sandstrom PA, Murray J, Folks TM, Diamond AM. Antioxidant defenses influence HIV-1 replication and associated cytopathic effects. Free Radic Biol Med. 1998;24:1485-1491.
6. Fuchs J, Milbradt R, Ochsendorf F, Rubsamen-Waigmann H, Schofer H. Oxidative imbalance in HIV-infected patients. Med Hypotheses. 1991;36:60-64.
7. Pace GW, Leaf CD. The role of oxidative stress in HIV disease. Free Radic Biol Med. 1995;19:523-528.
8. Lu J, Holmgren A. Selenoproteins. J Biol Chem. 2008;284:723-727.
9. Maddox JF, Aherne KM, Reddy CC, Sordillo LM. Increased neutrophil adherence and adhesion molecule mRNA expression in endothelial cells during selenium deficiency. J Leukoc Biol. 1999;65:658-664.
10. Rigelius-Flohé R. Tissue specific functions of individual glutathione peroxidases. Free Radic Biol Med. 1999;27:951-965.
11. Allmang C, Krol A. Selenoprotein synthesis: UGA does not end the story. Biochemie. 2006;88:1561-1571.
12. Moghadaszadeh B, Beggs AH. Selenoproteins and their impact on health through diverse physiological pathways. Physiology. 2006;21:307-315.
13. Beck MA, Esworthy RS, Ho YS, Chu FF. Glutathione peroxidase protects mice against viral induced myocarditis. FASEB J. 1998;12:1143-1149.
14. Cheng YY, Qian P. The effect of selenium fortified table salt in the prevention of Keshan disease in a population of 1.05 million. Biomed Environ Sci. 1990;3:422-488.
15. Poli G, Fauci AS. The effect of cytokines and pharmacological agents on chronic HIV infection. AIDS Res Hum Retroviruses. 1992;8:191-197.
16. Taylor EW. Selenium and cellular immunity. Evidence that selenoproteins may be encoded in the +1 reading frame overlapping the human CD4, CD8 and HLA-DR genes. Biol Trace Elem Res. 1995;49:85-95.
17. Taylor EW, Nadimpalli RG, Ramanathan CS. Genomic structures of viral agents in relation to the biosynthesis of selenoproteins. Biol Trace Elem Res. 1997;56:63-91.
18. Zhang W, Ramanathan CS, Nadimpalli RG, Bhat AA, Cox AG, Taylor EW. Selenium-dependent glutathione peroxidase modules encoded by RNA viruses. Biol Trace Elem Res. 1999;70:97-116.
19. Zhao L, Cox AG, Ruzicka JA, Bhat AA, Zhang W, Taylor EW. Molecular modeling and in vitro activity of an HIV-1-encoded glutathione peroxidase. Proc Natl Acad Sci USA. 2000;97:6356-6361.
20. Diamond AM, Kataoka Y, Murray J, Duan C, Folks TM, Sandstrom PA. A T-cell model for the biological role of selenium-dependent glutathione peroxidase. Biomed Environ Sci. 1997;10:246-252.
21. Makropoulos V, Brüning T, Schulze-Osthoff K. Selenium-mediated inhibition of transcription factor NF-kappa B and HIV-1 LTR promoter activity. Arch Toxicol. 1996;70:277-283.
22. Hori K, Hatfield D, Maldarelli F, Lee BJ, Clouse KA. Selenium supplementation suppresses tumor necrosis factor alpha-induced human immunodeficiency virus type 1 replication in vitro. AIDS Res Hum Retroviruses. 1997;13:1325-1332.
23. Gladyshev VM, Stadtman TC, Hatfield DL, Jeang KT. Levels of major selenoproteins decrease in HIV infection and low molecular mass compounds increase. Proc Natl Acad Sci U S A. 1999;96:835-839.
24. Roy M, Kiremidjian-Schumacher L, Wishe HI, Cohen MW, Stotzky G. Selenium supplementation enhances the expression of interleukin 2 receptor subunits and internalization of interleukin 2. Proc Soc Exp Biol Med. 1993;202:295-301.
25. Wu Y, Yang X. Enhancement of interleukin 2 production in human and gibbon T cells after in vitro treatment with lithium. Proc Soc Exp Biol Med. 1991;198:620-624.
26. Look MP, Rockstroh JK, Rao GS, Kreuzer KA, Spengler U, Sauerbruch T. Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodeficiency virus-1 infection. Biol Trace Elem Res. 1997;56:31.
27. Baum MK, Miguez-Burbano MJ, Campa A, Shor-Posner G. Selenium and interleukins in persons infected with human immunodeficiency type 1. J Infect Dis. 2000;182(Suppl 1):S69-S73.
28. Xu XM, Carlson BA, Grimm TA, et al. Rhesus monkey simian immunodeficiency virus infection as a model for assessing the role of selenium in AIDS. J Acquir Human Immune Defic Syndr. 2002;31:453-463.
29. Dworkin BM, Rosenthal WS, Wormser GP, et al. Abnormalities of blood selenium and glutathione peroxidase activity in patients with acquired immunodeficiency syndrome and AIDS-related complex. Biol Trace Elem Res. 1988;15:167-177.
30. Beck KW, Schramel P, Hedl A, Jaeger H, Kaboth W. Serum trace element levels in HIV-infected subjects. Biol Trace Elem Res. 1990;25:89-96.
31. Baum MK, Shor-Posner G, Zhang G, et al. HIV-1 infection in women is associated with severe nutritional deficiencies. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16:272-278.
32. Tohill BC, Heilig CM, Klein RS, et al. Nutritional biomarkers associated with gynecological conditions among US women with or at risk of HIV infection. Am J Clin Nutr. 2007;85:1327-1334.
33. Shor-Posner G, Campa A, Zhang G, et al. Better mental function and well-being are associated with higher selenium levels in the MIDAS (Miami HIV-1 infected drug abusers) study. Paper presented at: Biopsychosocial Aspects of HIV Infection Fourth International Conference, 1999.
34. Constans J, Peuchant E, Pellegrin JL, et al. Fatty acids and plasma antioxidants in HIV-positive patients: Correlation with nutritional and immunological status. Clin Biochem. 1995;28:421-426.
35. Delmas-Beauvieux MC, Peuchant E, Couchouron A, et al. The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: Effects of supplementation with selenium or beta-carotene. Am J Clin Nutr. 1996;64:101-107.
36. Kassu A, Yabutani T, Mahmud ZH, et al. Alterations in serum levels of trace elements in tuberculosis and HIV infection. Eur J Clin Nutr. 2006;60:580-586.
37. Baum MK, Shor Posner G, Lai S, et al. High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;15:370-374.
38. Kupka R, Msamanga GI, Spiegelman D, et al. Selenium status is associated with accelerated HIV disease progression among HIV-1-infected pregnant women. J Nutr. 2004;134:2556-2560.
39. Campa A, Shor-Posner G, Indacochea F, et al. Mortality risk in selenium-deficient HIV-positive children. J Acquir Hum Immunodefic Syndr Retroviruses. 1999;20:508-513.
40. Kupka R, Garland M, Msamanga GI, Spiegelman D, Hunter D, Fawzi WW. Selenium status, pregnancy outcomes and mother-to-child transmission of HIV-1. J Acquir Immune Defic Syndr. 2005;39:203-210.
41. Twagirumukiza M, Nkeramihigo E, Seminega B, Gasakure E, Boccara F, Barbaro G. Prevalence of dilated cardiomyopathy in HIV-infected African patients not receiving HAART: A multicenter, observational, prospective, cohort study in Rwanda. Curr HIV Res. 2007;5:129-137.
42. Kupka R, Msamanga GI, Xu C, Anderson D, Hunter D, Fawzi WW. Relationship between plasma selenium levels and lower genital tract levels of HIV-1 RNA and interleukin 1-B. Eur J Clin Nutr. 2007;61:542-547.
43. Shor-Posner G, Miguez MJ, Pineda LM, et al. Impact of selenium status on the pathogenesis of mycobacterial disease in HIV-1-infected drug users during the era of highly active antiretroviral therapy. J Acquir Hum Immune Defic Syndr. 2002;29:169-173.
44. Kupka R, Msamanga GI, Spiegelman D, Rifai N, Hunter DJ, Fawzi WW. Selenium levels in relation to morbidity and mortality among children born to HIV-infected mothers. Eur J Clin Nutr. 2005;59:1250-1258.
45. Rousseau MC, Molines C, Moreau J, Delmont J. Influence of highly active antiretroviral therapy on micronutrient profiles in HIV-infected patients. Ann Nutr Metab. 2000;44:212-216.
46. Zazzo JF, Chalas J, Lafont A, Camus F, Chappuis PH. Is non-obstructive cardiomyopathy in AIDS selenium-deficiency-related? J Parenter Enteral Nutr. 1988;12:537-538.
47. Olmstead L, Schrauzer GN, Flores-Arce M, Dowd J. Selenium supplementation of symptomatic human immunodeficiency virus infected patients. Biol Trace Elem Res. 1989;20:59-65.
48. Batterham M, Gold J, Naidoo D, et al. A preliminary open label dose comparison using an antioxidant regimen to determine the effect on viral load and oxidative stress in men with HIV/AIDS. Eur J Clin Nutr. 2001;55:107-114.
49. Burbano X, Miguez Burbano MJ, McCollister K, et al. Impact of a selenium chemoprevention clinical trial on hospital admissions of HIV-infected participants. HIV Clin Trials. 2002;3:483-491.
50. Hurwitz BE, Klaus JR, Llabre MM, et al. Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: A randomized controlled trial. Arch Intern Med. 2007;167:148-154.
51. Kelly P, Musonda R, Kafwembe E, Kaetano L, Keane E, Farthing M. Micronutrient supplementation in the AIDS diarrhoea-wasting syndrome in Zambia: A randomized controlled trial. AIDS. 1999;13:495-500.
52. McClelland RS, Baeten JM, Overbaugh J, et al. Micronutrient supplementation increases genital tract shedding of HIV-1 in women: Results of a randomized trial. J Acquir Immune Defic Syndr. 2004;37:1657-1663.
53. Durosinmi MA, Armistead H, Akinola NO, et al. Selenium and aspirin in people living with HIV and AIDS in Nigeria. Niger Postgrad Med J. 2008;15:215-218.
54. Kupka R, Mugusi F, Aboud S, et al. Randomized, double-blind, placebo-controlled trial of selenium supplements among HIV-infected pregnant women in Tanzania: Effects on maternal and child outcomes. Am J Clin Nutr. 2008;87:1802-1808.
55. Kupka R, Mugusi F, Aboud S, Hertzmark E, Spiegelman D, Fawzi WW. Effect of selenium supplements on hemoglobin and morbidity among HIV-infected Tanzanian women. Clin Inf Dis. 2009;48:1475-1478.
56. Dworkin BM. Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS). Chem Biol Interact. 1994;91:181-186.
57. Delmas-Beauvieux MC, Peuchant E, Couchouron A, et al. The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: Effects of supplementation with selenium or beta-carotene. Am J Clin Nutr. 1996;64:101-107.
58. Schumacher M, Peraire J, Domingo JL, Vidai F, Richart C, Corbella J. Trace elements in patients with HIV-1 infection. Int Conf AIDS. 1994;10:149.
59. Diplock AT. Indexes of selenium status in human populations. Am J Clin Nutr. 1993;57(Suppl):S256-S258.
60. Longnecker M, Stram DO, Taylor PR, et al. Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intake. Epidemiology. 1996;7:384-390.
61. Chan S, Gerson B, Reitz RE, Sadjadi SA. Technical and clinical aspects of spectrometric analysis of trace elements in clinical samples. Clin Lab Med. 1998;18:615-629.
62. Constans J, Conri C, Sergeant C. Selenium and HIV infection. selenium and HIV infection. Editorial comment/opinions. Nutrition. 1999;15:719-720.
63. Allavena C, Dousset B, May T, Dubois F, Canton P, Belleville F. Relationship of trace element, immunological markers, and HIV1 infection progression. Biol Trace Elem Res. 1995;47:133-138.
64. Cirelli A, Ciardi M, De Simone C, et al. Serum selenium concentration and disease progress in patients with HIV infection. Clin Biochem. 1991;24:211-214.
65. Revillard JP, Vincent C, Favier A, Richard MJ, Zittoun M, Kazatchkine M. Lipid peroxidation in human immunodeficiency virus infection. J Acquir Hum Immune Defic Syndr. 1992;5:637-638.
66. Sappey C, Leclercq P, Coudray C, Faure P, Micoud M, Favier A. Vitamin, trace element and peroxide status in HIV seropositive patients: Asymptomatic patients present a β-carotene deficiency. Clin Chim Acta. 1994;230:35-42.
67. Favier A, Sappey C, Leclerc P, Faure P, Micoud M. Antioxidant status and lipid peroxidation in patients infected with HIV. Chem Biol Interact. 1994;91:165-180.
68. Longombe AO, Arnaud J, M'Pio T, Favier AE. Serum selenium in HIV-infected Zairian patients. Trace Elem Med. 1994;11:99-100.
69. Abuye C, Tsegaye A, West CE, et al. Determinants of CD4 counts among HIV-negative Ethiopians: Role of body mass index, gender, cigarette smoking, Khat (Catha edulis) chewing, and possibly altitude? J Clin Immunol. 2005;25:127-133.
70. Jones CY, Tang AM, Forrester JE, et al. Micronutrient levels and HIV disease status in HIV-infected patients on highly active antiretroviral therapy in the Nutrition for Healthy Living cohort. J Acquir Immune Defic Syndr. 2006;43:475-482.
71. Ogunro PS, Ogungbamigbe TO, Elemie PO, Egbewale BE, Adewole TA. Plasma selenium concentration and glutathione peroxidase activity in HIV-1/AIDS infected patients: A correlation with the disease progression. Niger Postgrad Med J. 2006;13:1-5.
72. Drain PK, Baeten JM, Overbaugh J, et al. Low serum albumin and the acute phase response predict low serum selenium in HIV-1 infected women. BMC Infect Dis. 2006;19:85.
73. Stephenson CB, Marquis GS, Douglas SD, Kruzich LA, Wilson CM. Glutathione, glutathione peroxidase, and selenium status in HIV positive and HIV negative adolescents and young adults. Am J Clin Nutr. 2007;85:173-181.
74. Khalili H, Soudbakhsh A, Hajiabdolbaghi M, et al. Nutritional status and serum zinc and selenium levels in Iranian HIV-infected individuals. BMC Infect Dis. 2008;8:165.